The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year ...

Quantum Biopharma filed an innovation passport application in the U.K. to expedite the development and review of MS therapy ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

Columnist Ben Hofmeister reveals how MS heat sensitivity now hinders his ability to fully enjoy summer activities.